Embla Medical hf. (CPH:EMBLA)
Denmark · Delayed Price · Currency is DKK 28.35
-0.40 (-1.39%)
Sep 7, 2026, 11:04 AM CET
Embla Medical Market Cap
Embla Medical has a market cap or net worth of 12.24 billion as of September 4, 2026. Its market cap has decreased by -8.98% in one year.
Market Cap
12.24B
Enterprise Value
15.13B
Revenue
6.44B
Ranking
n/a
PE Ratio
20.07
Stock Price
28.35
ChartMarket Cap Chart
Since September 4, 2009, Embla Medical's market cap has increased from 2.33B to 12.24B, an increase of 426.30%. That is a compound annual growth rate of 10.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 12.24B | -11.84% |
| Dec 30, 2025 | 13.89B | -8.62% |
| Dec 30, 2024 | 15.20B | 31.74% |
| Dec 29, 2023 | 11.54B | -18.15% |
| Dec 30, 2022 | 14.10B | -21.07% |
| Dec 30, 2021 | 17.86B | -12.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.32T |
| Genmab | 129.25B |
| Coloplast | 102.38B |
| Demant | 61.54B |
| H. Lundbeck | 43.68B |
| Zealand Pharma | 20.80B |
| Ambu A/S | 17.95B |
| Bavarian Nordic | 16.32B |